The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
The facility will manufacture its Herceptin biosimilar, Tuznue
By connecting a leading LongBio VC to the DeSci (decentralized science) movement, this partnership is a major milestone for the greater decentralized ecosystem
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
The partnership is already underway having launched earlier last week, and the contract could be worth up to £211 million.
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
The brand has added a range of exciting new products especially formulated for oily skin.
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Subscribe To Our Newsletter & Stay Updated
